THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 105 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 56.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $176,052 | -71.6% | 20,400 | -65.9% | 0.00% | -100.0% |
| Q2 2023 | $619,054 | +96.5% | 59,812 | +299.0% | 0.00% | -50.0% |
| Q2 2020 | $315,000 | +71.2% | 14,990 | +83.7% | 0.00% | +100.0% |
| Q1 2019 | $184,000 | +76.9% | 8,160 | +100.0% | 0.00% | 0.0% |
| Q4 2018 | $104,000 | -99.2% | 4,080 | -99.0% | 0.00% | -98.8% |
| Q4 2016 | $13,035,000 | +355.0% | 408,880 | +417.1% | 0.09% | +330.0% |
| Q3 2016 | $2,865,000 | +432.5% | 79,068 | +233.5% | 0.02% | +300.0% |
| Q2 2016 | $538,000 | – | 23,706 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 10,898,879 | $264,297,000 | 23.51% |
| Foundation Asset Management, LP | 399,537 | $9,689,000 | 3.59% |
| Cormorant Asset Management, LP | 1,300,000 | $31,525,000 | 2.35% |
| Baupost Group | 9,309,168 | $225,747,000 | 2.18% |
| Old West Investment Management, LLC | 109,320 | $2,651,000 | 1.53% |
| SENZAR ASSET MANAGEMENT, LLC | 187,856 | $4,555,000 | 1.44% |
| Chescapmanager LLC | 350,631 | $8,503,000 | 1.27% |
| Virtus ETF Advisers LLC | 32,989 | $800,000 | 0.69% |
| Rock Springs Capital Management LP | 652,600 | $15,826,000 | 0.68% |
| NJ State Employees Deferred Compensation Plan | 34,142 | $828,000 | 0.15% |